Diabetic retinopathy as the leading cause of blindness and early predictor of cascading complications—risks and mitigation
M Kropp, O Golubnitschaja, A Mazurakova… - Epma Journal, 2023 - Springer
Proliferative diabetic retinopathy (PDR) the sequel of diabetic retinopathy (DR), a frequent
complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age …
complication of diabetes mellitus (DM), is the leading cause of blindness in the working-age …
Systematic review on barriers and enablers for access to diabetic retinopathy screening services in different income settings
MMPN Piyasena, GVS Murthy, JLY Yip, C Gilbert… - PloS one, 2019 - journals.plos.org
Background Diabetic retinopathy (DR) can lead to visual impairment and blindness if not
detected and treated in time. Knowing the barriers/enablers in advance in contrasting …
detected and treated in time. Knowing the barriers/enablers in advance in contrasting …
Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China
XM Huang, BF Yang, WL Zheng, Q Liu, F Xiao… - BMC Health Services …, 2022 - Springer
Background Diabetic retinopathy (DR) has become a leading cause of global blindness as a
microvascular complication of diabetes. Regular screening of diabetic retinopathy is strongly …
microvascular complication of diabetes. Regular screening of diabetic retinopathy is strongly …
Homocysteine: a potential biomarker for diabetic retinopathy
Diabetic retinopathy (DR) is the most common cause of blindness in people under the age of
65. Unfortunately, the current screening process for DR restricts the population that can be …
65. Unfortunately, the current screening process for DR restricts the population that can be …
Evidence‐based Danish guidelines for screening of diabetic retinopathy
J Grauslund, N Andersen, J Andresen… - Acta …, 2018 - Wiley Online Library
Purpose Diabetic retinopathy (DR) is among the leading causes of visual loss in the working‐
age population. It is generally accepted that screening of DR is cost‐effective and can detect …
age population. It is generally accepted that screening of DR is cost‐effective and can detect …
[HTML][HTML] The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases
LF Desideri, C Rutigliani, P Corazza, A Nastasi… - Journal of …, 2022 - Elsevier
In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is
attracting increasing global interest in the field of ophthalmology. DL models are considered …
attracting increasing global interest in the field of ophthalmology. DL models are considered …
Diabetic retinopathy leading to blindness-a review
Diabetic retinopathy (DR) is the most common microvascular complication of diabetes that
damages the retina, leading to blindness. People with type 1 diabetes are at greater risk of …
damages the retina, leading to blindness. People with type 1 diabetes are at greater risk of …
Racial/ethnic disparities and barriers to diabetic retinopathy screening in youths
Importance Diabetic retinopathy is a major complication of diabetes for which regular
screening improves visual health outcomes, yet adherence to screening is suboptimal …
screening improves visual health outcomes, yet adherence to screening is suboptimal …
Autonomous artificial intelligence for diabetic eye disease increases access and health equity in underserved populations
Diabetic eye disease (DED) is a leading cause of blindness in the world. Annual DED
testing is recommended for adults with diabetes, but adherence to this guideline has …
testing is recommended for adults with diabetes, but adherence to this guideline has …
Attendance in a national screening program for diabetic retinopathy: a population-based study of 205,970 patients
AS Thykjær, N Andersen, T Bek, S Heegaard, J Hajari… - Acta Diabetologica, 2022 - Springer
Aims A nationwide diabetic retinopathy (DR) screening program has been established in
Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings …
Denmark since 2013. We aimed to perform an evaluation of adherence to DR screenings …